ArticleDrug delivery and translational research2019

Polycaprolactone-based neurotherapeutic delivery of rasagiline targeting behavioral and biochemical deficits in Parkinson's disease.

N Kanwar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.